Playtika Holding Corp. - PLTK

PLTK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PLTK	0.7	2.4	13.9	25.6	-4.8	4.7	-60.8	-73.0	-73.0	-73.0
S&P 500	-0.6	-0.5	2.3	7.3	12.1	32.1	27.0	90.7	191.4	33587.3

Compare PLTK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PLTK
name	Playtika Holding Corp.
price	8.54
changes percentage	0.71
change	0.06
day low	8.42
day high	8.60
year high	9.22
year low	6.25
market cap	3182969020
price avg 50	7.77
price avg 200	7.63
exchange	NASDAQ
volume	510875
avg volume	674268
open	8.54
previous close	8.48
eps	0.58
pe	14.72
earnings announcement	2025-02-20T12:00:00.000+0000
shares outstanding	372713000
timestamp	2024-11-14 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 61.0%

Overall Quarterly Financial Health: 63.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001828016
revenue	2567000000	2615500000	-1.85
gross profit	1848500000	1879800000	-1.67
gross profit ratio	0.72	0.72	0.19
research and development expenses	406400000	472300000	-13.95
operating expenses	1280500000	1408400000	-9.08
interest income	42700000	14100000	202.84
interest expense	153500000	110600000	38.79
ebitda	703600000	640300000	9.89
ebitdaratio	0.27	0.18	52.08
operating income	568000000	309400000	83.58
operating income ratio	0.22	0.12	87.05
net income	235000000	275300000	-14.64
net income ratio	0.09	0.11	-13.03
eps	0.64	0.69	-7.25

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 2,567 million in 2023 from 2,616 million in 2022 representing a change of -1.85%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 1,848 million in 2023 from 1,880 million in 2022 representing a change of -1.67%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 406 million in 2023 from 472 million in 2022 representing a change of -13.95%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Net Income: Net income decreased to 235 million in 2023 from 275 million in 2022 representing a change of -14.64%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.64 in 2023 from 0.64 in 2022 representing a change of -7.25%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 1,280 million in 2023 from 1,408 million in 2022 representing a change of -9.08%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 704 million in 2023 from 640 million in 2022 representing a change of 9.89%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 568 million in 2023 from 309 million in 2022 representing a change of 83.58%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001828016
revenue	620800000	627000000	-0.99
gross profit	452700000	458800000	-1.33
gross profit ratio	0.73	0.73	-0.34
research and development expenses	99200000	100600000	-1.39
operating expenses	355199999	325200000	9.23
interest income	18400000	13700000	34.31
interest expense	39200000	38900000	0.77
ebitda	97500000	197600000	-50.66
ebitdaratio	0.16	0.27	-42.85
operating income	97500000	133600000	-27.02
operating income ratio	0.16	0.21	-26.29
net income	39300000	86600000	-54.62
net income ratio	0.06	0.14	-54.17
eps	0.11	0.23	-52.17

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 621 million in 2024Q3 from 627 million in 2024Q2 representing a change of -0.99%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 453 million in 2024Q3 from 459 million in 2024Q2 representing a change of -1.33%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 355 million in 2024Q3 from 325 million in 2024Q2 representing a change of 9.23%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 39 million in 2024Q3 from 87 million in 2024Q2 representing a change of -54.62%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.11 in 2024Q3 from 0.11 in 2024Q2 representing a change of -52.17%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 99 million in 2024Q3 from 101 million in 2024Q2 representing a change of -1.39%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 98 million in 2024Q3 from 198 million in 2024Q2 representing a change of -50.66%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 98 million in 2024Q3 from 134 million in 2024Q2 representing a change of -27.02%. The increase in operating income indicates better operational performance and increased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001828016
total assets	3175000000	2697600000	17.70
total liabilities	3396500000	3266200000	3.99
total equity	-221500000	-568600000	61.04
cash and cash equivalents	1029700000	768700000	33.95
short term investments	25300000	19500000	29.74
long term investments	69600000	52600000	32.32
total current assets	1351100000	1024900000	31.83
total non current assets	1823900000	1672700000	9.04
total current liabilities	539600000	461800000	16.85
total non current liabilities	2856900000	2804400000	1.87
common stock	4099999	4100000	-0.00
retained earnings	-907600000	-1142600000	20.57
total debt	2524100000	2531600000	-0.30

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,175 million in 2023 from 2,698 million in 2022 representing a change of 17.7%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to -222 million in 2023 from -569 million in 2022 representing a change of 61.04%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,030 million in 2023 from 769 million in 2022 representing a change of 33.95%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 25 million in 2023 from 20 million in 2022 representing a change of 29.74%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,351 million in 2023 from 1,025 million in 2022 representing a change of 31.83%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to -908 million in 2023 from -1,143 million in 2022 representing a change of 20.57%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2,524 million in 2023 from 2,532 million in 2022 representing a change of -0.3%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 3,396 million in 2023 from 3,266 million in 2022 representing a change of 3.99%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 540 million in 2023 from 462 million in 2022 representing a change of 16.85%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 4 in 2023 from 4 in 2022 representing a change of -0.0%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001828016
total assets	3189100000	3175300000	0.43
total liabilities	3287100000	3288200000	-0.03
total equity	-98000000	-112900000	13.20
cash and cash equivalents	1145900000	711800000	60.99
short term investments	55800000	390100000	-85.70
long term investments	19100000	66099999	-71.10
total current assets	1470100000	1399000000	5.08
total non current assets	1719000000	1776300000	-3.23
total current liabilities	452100000	461700000	-2.08
total non current liabilities	2835000000	2826500000	0.30
common stock	4100000	4099999	0.00
retained earnings	-840300000	-842300000	0.24
total debt	2500200000	2509000000	-0.35

Overall Score of Quarterly Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,189 million in 2024Q3 from 3,175 million in 2024Q2 representing a change of 0.43%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 3,287 million in 2024Q3 from 3,288 million in 2024Q2 representing a change of -0.03%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to -98 million in 2024Q3 from -113 million in 2024Q2 representing a change of 13.2%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,146 million in 2024Q3 from 712 million in 2024Q2 representing a change of 60.99%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,470 million in 2024Q3 from 1,399 million in 2024Q2 representing a change of 5.08%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 452 million in 2024Q3 from 462 million in 2024Q2 representing a change of -2.08%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 4 in 2024Q3 from 4 in 2024Q2 representing a change of 0.0%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -840 million in 2024Q3 from -842 million in 2024Q2 representing a change of 0.24%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2,500 million in 2024Q3 from 2,509 million in 2024Q2 representing a change of -0.35%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 56 million in 2024Q3 from 390 million in 2024Q2 representing a change of -85.7%. This indicates a decrease in short-term investment holdings.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001828016
net change in cash	261300000	-248600000	205.11
operating cash flow	515600000	493700000	4.44
free cash flow	436400000	383700000	13.73
capital expenditure	-32600000	-110000000	70.36
depreciation and amortization	158000000	162000000	-2.47
deferred income tax	-46600000	-46000000	-1.30
stock based compensation	110000000	123500000	-10.93
accounts payables	-9300000	5700000	-263.16
inventory	0	0	NaN
acquisitions net	-159600000	-64700000	-146.68
investments in property plant and equipment	-32600000	-110000000	70.36
net cash used for investing activites	-240200000	-74600000	-221.98
debt repayment	-14300000	-19000000	24.74
common stock issued	0	606100000	-100.00
common stock repurchased	-3900000	-2600000	-50.00
dividends paid	0	-603500000	100.00
net cash used provided by financing activities	-18200000	-652000000	97.21
cash at end of period	1031700000	770400000	33.92
accounts receivables	-25600000	1000000	-2,660.00
cash at beginning of period	770400000	1019000000	-24.40

Overall Score of Annual Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 261 million in 2023 from -249 million in 2022 representing a change of 205.11%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 516 million in 2023 from 494 million in 2022 representing a change of 4.44%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 436 million in 2023 from 384 million in 2022 representing a change of 13.73%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 110 million in 2023 from 124 million in 2022 representing a change of -10.93%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -26 million in 2023 from 1 million in 2022 representing a change of -2660.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 0 million in 2023 from -604 million in 2022 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -33 million in 2023 from -110 million in 2022 representing a change of 70.36%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 9 million in 2023 from 6 million in 2022 representing a change of -263.16%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001828016
operating cash flow	158375938	149024062	6.28
free cash flow	187800622	126399378	48.58
capital expenditure	29424684	-22624684	230.06
depreciation and amortization	39200000	38700000	1.29
deferred income tax	-3052449	-2747551	-11.10
stock based compensation	23600000	22900000	3.06
accounts receivables	1586869	11613131	-86.34
accounts payables	17518908	-36518908	147.97
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	29424684	-22624684	230.06
net cash used for investing activites	319919581	-409519581	178.12
debt repayment	-9500000	-4622146	-105.53
common stock issued	0	0	NaN
common stock repurchased	1300000	-600000	316.67
dividends paid	-37504039	-36795961	-1.92
net cash used provided by financing activities	-47898282	-42701718	-12.17
net change in cash	435600000	-305700000	242.49
cash at end of period	1147400000	711800000	61.20
cash at beginning of period	711800000	1017500000	-30.04

Overall Score of Quarterly Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 436 million in 2024Q3 from -306 million in 2024Q2 representing a change of 242.49%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 158 million in 2024Q3 from 149 million in 2024Q2 representing a change of 6.28%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 188 million in 2024Q3 from 126 million in 2024Q2 representing a change of 48.58%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 18 million in 2024Q3 from 37 million in 2024Q2 representing a change of 147.97%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 2 million in 2024Q3 from 12 million in 2024Q2 representing a change of -86.34%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 29 million in 2024Q3 from -23 million in 2024Q2 representing a change of 230.06%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 24 million in 2024Q3 from 23 million in 2024Q2 representing a change of 3.06%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -38 million in 2024Q3 from -37 million in 2024Q2 representing a change of -1.92%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	7.01	6.52	7.44
net income per share	0.64	0.69	-6.55
operating cash flow per share	1.41	1.23	14.33
free cash flow per share	1.19	0.96	24.51
cash per share	2.88	1.97	46.53
book value per share	-0.6	-1.42	57.35
tangible book value per share	-4.15	-4.32	4.03
shareholders equity per share	-0.6	-1.42	57.35
interest debt per share	7.07	6.59	7.29
market cap	3194136000	3412510000	-6.40
enterprise value	4688536000	5175410000	-9.41
pe ratio	13.59	12.4	9.65
price to sales ratio	1.24	1.3	-4.63
pocfratio	6.19	6.91	-10.37
pfcf ratio	7.32	8.89	-17.70
pb ratio	-14.42	-6.0	-140.28
ptb ratio	-14.42	-6.0	-140.28
ev to sales	1.83	1.98	-7.70
enterprise value over ebitda	6.66	8.08	-17.56
ev to operating cash flow	9.09	10.48	-13.26
ev to free cash flow	10.74	13.49	-20.35
earnings yield	0.07	0.08	-8.80
free cash flow yield	0.14	0.11	21.51
debt to equity	-11.0	-4.45	-147.00
debt to assets	0.77	0.94	-18.25
net debt to ebitda	2.12	2.75	-22.86
current ratio	2.5	2.22	12.82
interest coverage	3.7	2.8	32.27
income quality	2.19	1.79	22.35
dividend yield	0	0.18	-100.00
payout ratio	0	2.19	-100.00
sales general and administrative to revenue	0.12	0.13	-6.97
research and ddevelopement to revenue	0.16	0.18	-12.33
intangibles to total assets	0.41	0.43	-5.32
capex to operating cash flow	0.06	0.22	-71.62
capex to revenue	0.01	0.04	-69.80
capex to depreciation	0.21	0.68	-69.61
stock based compensation to revenue	0.04	0.05	-9.25
graham number	2.95	4.68	-36.87
roic	0.15	0.12	27.83
return on tangible assets	0.13	0.18	-30.30
graham net net	-6.04	-5.91	-2.16
working capital	811500000	563100000	44.11
tangible asset value	-1519900000	-1733800000	12.34
net current asset value	-2045400000	-2241300000	8.74
invested capital	2330100000	1958200000	18.99
average receivables	156300000	142400000	9.76
average payables	57850000	48200000	20.02
average inventory	850000	12200000	-93.03
days sales outstanding	24.39	19.69	23.84
days payables outstanding	33.02	25.15	31.27
days of inventory on hand	0	0.84	-100.00
receivables turnover	14.97	18.54	-19.25
payables turnover	11.05	14.51	-23.82
inventory turnover	0	432.76	-100.00
roe	-1.06	-0.48	-119.13
capex per share	0.09	0.27	-67.56

• Negative

  ROE: Return on Equity (ROE) decreased to -1.06 on 2023-12-31 from -0.48 on 2022-12-31, representing a change of -119.13%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 13.59 on 2023-12-31 from 12.40 on 2022-12-31, representing a change of 9.65%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.50 on 2023-12-31 from 2.22 on 2022-12-31, representing a change of 12.82%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -11.00 on 2023-12-31 from -4.45 on 2022-12-31, representing a change of -147.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
PLTK
calendar year	2024	2024	NaN
revenue per share	1.67	1.69	-1.20
net income per share	0.11	0.23	-54.72
operating cash flow per share	0.43	0.4	6.05
free cash flow per share	0.5	0.34	48.26
cash per share	3.23	2.97	8.82
book value per share	-0.26	-0.3	13.38
tangible book value per share	-0.97	-3.71	73.81
shareholders equity per share	-0.26	-0.3	13.38
interest debt per share	6.82	6.65	2.66
market cap	2947824000	2740932000	7.55
enterprise value	4302124000	4538132000	-5.20
pe ratio	18.75	7.91	136.99
price to sales ratio	4.75	4.37	8.62
pocfratio	18.61	18.39	1.20
pfcf ratio	15.7	21.68	-27.61
pb ratio	-30.08	-24.28	-23.90
ptb ratio	-30.08	-24.28	-23.90
ev to sales	6.93	7.24	-4.25
enterprise value over ebitda	44.12	22.97	92.13
ev to operating cash flow	27.16	30.45	-10.80
ev to free cash flow	22.91	35.9	-36.20
earnings yield	0.01	0.03	-57.80
free cash flow yield	0.06	0.05	38.15
debt to equity	-25.51	-21.52	-18.56
debt to assets	0.78	0.77	2.46
net debt to ebitda	13.89	9.1	52.72
current ratio	3.25	3.03	7.31
interest coverage	2.49	3.43	-27.58
income quality	4.03	1.72	134.18
dividend yield	0.01	0.01	-5.23
payout ratio	0.95	0.42	124.60
sales general and administrative to revenue	0.12	0.08	61.26
research and ddevelopement to revenue	0.16	0.16	-0.41
intangibles to total assets	0.08	0.4	-79.25
capex to operating cash flow	0.19	0.15	22.38
capex to revenue	0.05	0.04	31.35
capex to depreciation	0.75	0.58	28.40
stock based compensation to revenue	0.04	0.04	4.09
graham number	0.79	1.26	-37.37
roic	0.03	0.04	-39.68
return on tangible assets	0.01	0.05	-70.38
graham net net	-5.28	-5.58	5.34
working capital	1018000000	937300000	8.61
tangible asset value	-361800000	-1378700000	73.76
net current asset value	-1817000000	-1889200000	3.82
invested capital	1482600000	2409300000	-38.46
average receivables	165250000	171450000	-3.62
average payables	25050000	35500000	-29.44
average inventory	-13900000	-27800000	50.00
days sales outstanding	23.14	24.53	-5.68
days payables outstanding	19.54	7.28	168.54
days of inventory on hand	0	-14.88	100.00
receivables turnover	3.89	3.67	6.02
payables turnover	4.61	12.37	-62.76
inventory turnover	0	-6.05	100.00
roe	-0.4	-0.77	47.72
capex per share	0.08	0.06	29.78

• Negative

  ROE: Return on Equity (ROE) increased to -0.40 on 2024-09-30 Q3 from -0.77 on 2024-06-30 Q2, representing a change of 47.72%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 3.25 on 2024-09-30 Q3 from 3.03 on 2024-06-30 Q2, representing a change of 7.31%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 18.75 on 2024-09-30 Q3 from 7.91 on 2024-06-30 Q2, representing a change of 136.99%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -25.51 on 2024-09-30 Q3 from -21.52 on 2024-06-30 Q2, representing a change of -18.56%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None